PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.

Subjects

Subjects :

HER2 positive breast cancer
SOMATIC mutation
METASTATIC breast cancer
DRUG resistance in cancer cells
NUCLEIC acid isolation methods
BREAST

Details

Language :

English

ISSN :

00219746

Volume :

77

Issue :

10

Database :

Complementary Index

Journal :

Journal of Clinical Pathology

Publication Type :

Academic Journal

Accession number :

180483013

Full Text :

https://doi.org/10.1136/jcp-2023-208856